Skip to main content

What the FDA labels say about taking them together

Erlotinib and nelfinavir

Erlotinib's FDA label of June 10, 2024 names nelfinavir in its drug interactions section; the nelfinavir label PlainMeds reads does not name erlotinib. The erlotinib label: “Avoid co-administering erlotinib with strong CYP3A4 inhibitors or a combined CYP3A4 and CYP1A2 inhibitor (e.g., ciprofloxacin).”

Check it at the source: the erlotinib FDA label on DailyMed (effective June 10, 2024, Alembic Pharmaceuticals Limited); the nelfinavir FDA label on DailyMed (effective December 11, 2025, AGOURON).

What does the erlotinib label say about nelfinavir?

Erlotinib label, drug interactions

Avoid co-administering erlotinib with strong CYP3A4 inhibitors (e.g., boceprevir, clarithromycin, conivaptan, indinavir, itraconazole, ketoconazole, lopinavir/ritonavir, nefazodone, nelfinavir, posaconazole, ritonavir, saquinavir, telithromycin, voriconazole, grapefruit or grapefruit juice) or a combined CYP3A4 and CYP1A2 inhibitor (e.g., ciprofloxacin).

Source: FDA drug label (ERLOTINIB HYDROCHLORIDE), Alembic Pharmaceuticals Limited, effective June 10, 2024 (SPL set ab6f3cb3-34a8-4492-a5d7-fb6b055a2d6b), via openFDA; the full label on DailyMed

What does the nelfinavir label say about erlotinib?

Nelfinavir's label (effective December 11, 2025) does not name erlotinib in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (VIRACEPT), AGOURON, effective December 11, 2025 (SPL set e72c2bc6-9462-4a2e-8e1d-b97592376cbd), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

10Erlotinib generic labelers
0Nelfinavir generic labelers
ErlotinibNelfinavir
Labeled forLung cancerHIV
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?